Top Markets
#1 Glidr Glidr +45.67%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#3 Movement Movement +9.79%
#4 Victoria VR Victoria VR +7.64%
#5 DMT-NAT DMT-NAT +7.02%
#6 Pons Pons +6.47%
#7 MarsCoin MarsCoin +5.30%
#8 Cryptopia Cryptopia +5.23%
#9 Lisk Lisk +5.01%
#10 Jito Jito +4.63%
Coin of the day
Glidr Glidr
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Classifica tra le azioni #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Prezzo delle azioni
$0.0009
Ultima sincronizzazione: 2025-05-27
Capitalizzazione di mercato
$1.15K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Arch Therapeutics, Inc. (ARTH)

Categoria

Healthcare
EPS per Arch Therapeutics, Inc. (ARTH)
EPS al June 2024 TTM: $-2.86
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Arch Therapeutics, Inc., l’EPS attuale della società (TTM) è $-2.86. Alla fine del 2022, la società aveva un EPS di $-3.56 una diminuzione rispetto a rispetto a quello del 2021, che era di $-5.97.
Storico EPS per Arch Therapeutics, Inc. da 2011 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-2.86 25.99%
2023 $-2.27 -36.24%
2022 $-3.56 -40.37%
2021 $-5.97 39.81%
2020 $-4.27 30.58%
2019 $-3.27 -48.10%
2018 $-6.30 -42.25%
2017 $-10.91 10.54%
2016 $-9.87 36.33%
2015 $-7.24 -70.00%
2014 $-24.13 114.11%
2013 $-11.27 766.92%
2012 $-1.30 1,424.03%
2011 $-0.09 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -705.59%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -1,069.93%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -579.02%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR